In an article published on May 18, 2017 regulatory news provider Chemical Watch informed about an expert survey conducted by the European Commission’s (EC) Joint Research Centre (JRC) on “Identification of gaps in available test methods for evaluation of endocrine disruptors.” A selected group of experts, representing authorities, academia, civil society organizations, and industry, was invited to take part in the survey from May 19 to June 15 2015.
The experts suggested to update the test guidelines by the Organisation for Economic Co-operation and Development (OECD) with new endocrine disrupting endpoints, Chemical Watch reported. Regarding new or enhanced test methods for relevant endocrine-related diseases or disorders, thyroid-related disorders and neurodevelopmental disorders in children were given the highest priority, followed by metabolic and immune-related disorders, as well as hormone-related cancers.
The survey results will be used as a basis for discussion at an expert workshop on setting priorities for the further development and validation of test methods to identify endocrine disrupting chemicals (EDCs), organized by the EC’s Directorate-General for Environment (DG Environment) and taking place on May 30 – June 1, 2017 in Brussels, Belgium.
Read more
Chemical Watch (May 18, 2017). “OECD test guidelines should have new endocrine disrupting endpoints, says JRC.”
JRC (May 17, 2017). “Expert survey on identification of gaps in available test methods for evaluation of endocrine disruptors.”
Reference
Bopp S. et al. (2017). “Expert survey on identification of gaps in available test methods for evaluation of endocrine disruptors.” JRC Technical Reports EUR 28592 EN (pdf)
